GIM
MLAB icon

Granahan Investment Management’s Mesa Laboratories MLAB Stock Holding History

Granahan Investment Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,633
Closed -$5.93M – 195
2024
Q3 		$5.93M Sell
45,633
-8,791
-16% -$1.03M 0.23% 111
2024
Q2 		$4.72M Buy
54,424
+2,243
+4% +$235K 0.19% 129
2024
Q1 		$5.73M Sell
52,181
-19,705
-27% -$1.99M 0.2% 123
2023
Q4 		$7.53M Buy
71,886
+8,013
+13% +$781K 0.25% 106
2023
Q3 		$6.71M Buy
63,873
+11,517
+22% +$1.48M 0.24% 109
2023
Q2 		$6.73M Buy
52,356
+14,445
+38% +$2.2M 0.21% 116
2023
Q1 		$6.62M Buy
37,911
+4,017
+12% +$720K 0.2% 109
2022
Q4 		$5.63M Sell
33,894
-1,001
-3% -$157K 0.17% 121
2022
Q3 		$4.91M Sell
34,895
-31,955
-48% -$5.83M 0.16% 127
2022
Q2 		$13.6M Buy
66,850
+9,583
+17% +$2.1M 0.47% 65
2022
Q1 		$14.6M Buy
57,267
+10,649
+23% +$2.89M 0.36% 71
2021
Q4 		$15.3M Buy
46,618
+35,946
+337% +$11.3M 0.31% 91
2021
Q3 		$3.23M Buy
+10,672
New +$3.03M 0.06% 172

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Granahan Investment Management's MLAB Position: Q4 2024 in Review

Granahan Investment Management sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 45,633 shares — an estimated $5.93M sold.

Granahan Investment Management first reported a position in MLAB in Q3 2021 and held it in 13 quarters. The position peaked at $15.3M in Q4 2021. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Granahan Investment Management reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Granahan Investment Management sold 45,633 Mesa Laboratories shares in Q4 2024, an estimated $5.93M.
  • Granahan Investment Management first reported a position in Mesa Laboratories in Q3 2021 and held it in 13 quarters.
  • Granahan Investment Management's Mesa Laboratories position peaked at $15.3M in Q4 2021.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Granahan Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.